Orchestra BioMed Holdings, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Orchestra BioMed Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2022 to Q4 2023.
  • Orchestra BioMed Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $60.1M, a 29.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $60.1M +$13.7M +29.4% Dec 31, 2023 10-K 2024-03-27
Q4 2022 $46.5M Dec 31, 2022 10-K 2024-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.